Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARBAMAZEPINE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where CARBAMAZEPINE was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for CARBAMAZEPINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 2,661 10.8% 91 766
Seizure 2,262 9.2% 62 554
Toxicity to various agents 1,951 7.9% 575 1,289
Fall 1,368 5.6% 28 992
Off label use 1,198 4.9% 77 554
Drug reaction with eosinophilia and systemic symptoms 1,149 4.7% 51 774
Rash 991 4.0% 53 531
Pain 983 4.0% 18 698
Drug interaction 981 4.0% 92 476
Balance disorder 968 3.9% 5 750
Hypotension 955 3.9% 30 831
Pyrexia 950 3.9% 41 657
Dizziness 932 3.8% 9 365
Somnolence 925 3.8% 20 392
Vomiting 878 3.6% 31 637

Other Indications for CARBAMAZEPINE

Product used for unknown indication (8,167) Epilepsy (4,329) Seizure (2,310) Trigeminal neuralgia (1,490) Partial seizures (631) Bipolar disorder (497) Neuralgia (367) Generalised tonic-clonic seizure (355) Seizure prophylaxis (352) Pain (305)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

CARBAMAZEPINE Full Profile All Relapsing-remitting multiple sclerosis Drugs CARBAMAZEPINE Demographics CARBAMAZEPINE Timeline